Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer CellsPatricia M. Schnepp, Evan T. Keller|Molecular Cancer Research|2020Cited by 60
A CXCR4 inhibitor (balixafortide) enhances docetaxel‐mediated antitumor activity in a murine model of prostate cancer bone metastasisTyler Robinson, Evan T. Keller|The Prostate|2023Cited by 20
Targeted Notch1 inhibition with a Notch1 antibody, OMP‐A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expressionAqila Ahmed, Evan T. Keller|Journal of Cellular Biochemistry|2019Cited by 13
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate CancerPatricia M. Schnepp, Evan T. Keller|BMC Cancer|2021Cited by 12
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of LovastatinChanjuan Zheng, Xiyun Deng, Lu Lu et al.|International Journal of Biological Sciences|2024Cited by 7